Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions

Kishi K., Homma S., Sakamoto S., Kawabata M., Tsuboi E., Nakata K., Yoshimura K.

Source: Eur Respir J 2004; 24: 263-266
Journal Issue: August
Disease area: Respiratory infections, Thoracic oncology

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Kishi K., Homma S., Sakamoto S., Kawabata M., Tsuboi E., Nakata K., Yoshimura K.. Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions. Eur Respir J 2004; 24: 263-266

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pleurodesis of malignant pleural effusion with OK432
Source: Eur Respir J 2003; 22: Suppl. 45, 61s
Year: 2003

Talc chemotherapeutic pleurodesis to palliate malignant pleural effusions secondary to breast cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 509s
Year: 2003

Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients
Source: Eur Respir J 2011; 38: 1425-1430
Year: 2011



Systemic treatment of malignant pleural effusion
Source: Annual Congress 2005 - What's new in the pleura
Year: 2005


Hypotonic carboplatin pleurodesis for malignant pleural effusion of non-small cell lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 273s
Year: 2002

Pleurodesis in the treatment of malignant pleural effusion
Source: Eur Respir J 2004; 24: Suppl. 48, 628s
Year: 2004

Videothoracoscopy in the treatment of malignant pleural effusions
Source: Annual Congress 2009 - Pleural and mediastinal diseases
Year: 2009

Talc mediates angiostasis in malignant pleural effusions via endostatin induction
Source: Eur Respir J 2007; 29: 761-769
Year: 2007



Efficacy of talc pleurodesis in patients with malignant pleural effusions
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011


Chemotherapy for treatment of malignant pleural mesothelioma
Source: Eur Respir J 2004; 24: Suppl. 48, 526s
Year: 2004

Talc pleurodesis in malignant pleural effusions
Source: Eur Respir J 2001; 18: Suppl. 33, 386s
Year: 2001

Talc slurry vs bleomycin in treatment of malignant pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 448s
Year: 2005

Optimal treatment of pleurodesis for malignant pleural effusion in 2017
Source: ERS Skills course - Medical thoracoscopy
Year: 2017

Pleurodesis for malignant pleural effusion
Source: School Course 2014 - Medical Thoracoscopy
Year: 2014

Pleurodesis for malignant pleural effusion
Source: ERS Course 2016 - Skills course on medical thoracoscopy
Year: 2016

Malignant pleural effusions
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=177
Year: 2002

Malignant pleural disease in primary lung cancer
Source: Eur Respir Mon; 2009: 44: 318–335
Year: 2009

Management of malignant pleural effusion in recurrent SCLC by intrapleural gene therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 61s
Year: 2003

Efficacy of rapid pleurodesis in malignat pleural effusions
Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Year: 2010

Pleurodesis with erythromycin in large and recurrent malignant pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 72s
Year: 2005